Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases
|
May 3, 2012
A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature
Elena Elli, Caterina Cecchetti, Angelo Belotti, et al.
American Journal of Hematology
|
December 23, 2011
Circulating endothelial cells and endothelial activation in essential thrombocythemia: results from CD146+ immunomagnetic enrichment--flow cytometry and soluble E-selectin detection
Angelo Belotti, Elena Elli, Tiziana Speranza, et al.
Blood Reviews
|
April 28, 2018
Iron toxicity - Its effect on the bone marrow
Alessandro Isidori, Lorenza Borin, Elena Elli, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
June 16, 2015
Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission
Matteo Parma, Clara Viganò, Monica Fumagalli, et al.
Transfusion
|
July 1, 2005
Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate
Paolo Perseghin, Carlo Gambacorti-Passerini, Lucia Tornaghi, et al.
American Journal of Hematology
|
November 23, 2013
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
Maria Luigia Randi, Irene Bertozzi, Elisa Rumi, et al.
Hematological Oncology
|
May 4, 2019
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors
Alessandro Andriani, Elena Elli, Giulio Trapè, et al.
British Journal of Haematology
|
August 19, 2014
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
Federico Lussana, Alessandra Carobbio, Maria L Randi, et al.
American Journal of Hematology
|
January 7, 2010
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia
Valerio De Stefano, Tommaso Za, Elena Rossi, et al.
Annals of Hematology
|
July 8, 2009
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
Valerio De Stefano, Tommaso Za, Elena Rossi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Mediterranean Journal of Hematology and Infectious Diseases
|
May 3, 2012
A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature
Elena Elli, Caterina Cecchetti, Angelo Belotti, et al.
American Journal of Hematology
|
December 23, 2011
Circulating endothelial cells and endothelial activation in essential thrombocythemia: results from CD146+ immunomagnetic enrichment--flow cytometry and soluble E-selectin detection
Angelo Belotti, Elena Elli, Tiziana Speranza, et al.
Blood Reviews
|
April 28, 2018
Iron toxicity - Its effect on the bone marrow
Alessandro Isidori, Lorenza Borin, Elena Elli, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
June 16, 2015
Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission
Matteo Parma, Clara Viganò, Monica Fumagalli, et al.
Transfusion
|
July 1, 2005
Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate
Paolo Perseghin, Carlo Gambacorti-Passerini, Lucia Tornaghi, et al.
American Journal of Hematology
|
November 23, 2013
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
Maria Luigia Randi, Irene Bertozzi, Elisa Rumi, et al.
Hematological Oncology
|
May 4, 2019
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors
Alessandro Andriani, Elena Elli, Giulio Trapè, et al.
British Journal of Haematology
|
August 19, 2014
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
Federico Lussana, Alessandra Carobbio, Maria L Randi, et al.
American Journal of Hematology
|
January 7, 2010
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia
Valerio De Stefano, Tommaso Za, Elena Rossi, et al.
Annals of Hematology
|
July 8, 2009
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
Valerio De Stefano, Tommaso Za, Elena Rossi, et al.
Page
of 2